Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States
Author(s) -
Joshua A. Barocas,
Abriana Tasillo,
Golnaz Eftekhari Yazdi,
Jianing Wang,
Claudia Vellozzi,
Susan Hariri,
Cheryl Isenhour,
Liisa M. Randall,
John W. Ward,
Jonathan Mermin,
Joshua A. Salomon,
Benjamin P. Linas
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy098
Subject(s) - medicine , population , life expectancy , test strategy , cost effectiveness , cohort , observational study , hepatitis c , quality adjusted life year , hepatitis c virus , environmental health , immunology , risk analysis (engineering) , virus , software , computer science , programming language
The US Centers for Disease Control and Prevention and the U.S. Preventive Services Task Force recommend one-time hepatitis C virus (HCV) testing for persons born 1945-1965 and targeted testing for high-risk persons. This strategy targets HCV testing to a prevalent population at high risk for HCV morbidity and mortality, but does not include younger populations with high incidence. To address this gap and improve access to HCV testing, age-based strategies should be considered.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom